Observations placeholder
Bromocriptine and psychosis
Identifier
005257
Type of Spiritual Experience
Background
A description of the experience
Psychiatr Q. 1995 Spring;66(1):87-95. Bromocriptine and psychosis: a literature review. Boyd A Tulane Medical Center, Department of Psychiatry and Neurology, Tulane University, New Orleans, Louisiana.
Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of Parkinson's disease, postpartum ablaction, prolactinomas, acromegaly, and amenorrhea and galactorrhea secondary to neuroleptic use. It is often reported to produce psychiatric side effects such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocriptine use and psychosis.
PMID: 7701022